TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Changes in company's own shares

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Changes in company's own shares

Alvotech announced the European launch of AVT05, its first-in-market biosimilar to Simponi (golimumab), in partnership with Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom. The company also published its 2026 financial calendar.

Insights
FNGU   neutral

Proposed a modular approach to AI agents, focusing on specialized, discrete task performance


ALVO   positive

Company achieved a significant milestone with the European launch of its first-in-market biosimilar, supported by NHS England tender award, indicating market validation and commercial progress.